$1.68
-0.16-8.70%
At close: -
$1.69
0.010.60%
After Hours: 4:56 PM EDT
Comments
Loading...
Latest Armata Pharmaceuticals Stock News | AMEX:ARMP | Benzinga
Get the latest news on Armata Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Armata Pharmaceuticals performance
Categories: All
Thursday, March 20, 2025
Wednesday, March 12, 2025
Thursday, December 19, 2024
Thursday, November 14, 2024
Wednesday, November 13, 2024
Tuesday, November 12, 2024
Thursday, August 15, 2024
Tuesday, August 13, 2024
Tuesday, July 30, 2024
Thursday, July 11, 2024
Wednesday, July 10, 2024
Wednesday, May 08, 2024
Tuesday, May 07, 2024
Friday, March 22, 2024
Thursday, March 21, 2024
Monday, March 04, 2024
Wednesday, January 10, 2024
Tuesday, November 14, 2023
Monday, October 30, 2023
Tuesday, September 26, 2023
Tuesday, August 22, 2023
Monday, August 14, 2023
Thursday, July 27, 2023
Wednesday, July 26, 2023
Tuesday, July 25, 2023
Monday, July 24, 2023
Tuesday, July 11, 2023
Thursday, June 01, 2023
Thursday, May 18, 2023
Friday, May 12, 2023
Monday, May 08, 2023
Friday, March 17, 2023
Thursday, March 16, 2023
Tuesday, March 07, 2023
Monday, March 06, 2023
- Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Investors Cheer Armata Pharma's Encouraging Data From Lung Infection Candidate
- Armata Pharmaceuticals shares are trading hig...
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Armata Pharmaceuticals Announced Topline Data from Phase 1b/2a SWARM-P.a. Clinical Trial of Inhaled AP-PA02 in Patients with Cystic Fibrosis